Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
The price target boosts come after LLY stock rose 30% during November amid a strong rally in the shares. The bull run comes ...
Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...
Zacks Investment Research on MSN
Eli Lilly and Company (LLY) is a trending stock: Facts to know before betting on it
Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
The average one-year price target for Eli Lilly and (XTRA:LLY) has been revised to 880,84 € / share. This is an increase of 11.77% from the prior estimate of 788,08 € dated November 9, 2025. The price ...
In this photo illustration, a Eli Lilly logo seen displayed on a smartphone. Eli Lilly’s stock (NYSE: LLY) has recently surged 27% over the past month, reaching a current price of $1,022. This rally ...
Eli Lilly and Company’s LLY stock has risen 9.5% in a month, mainly due to the recent recovery in the pharma sector. The drug and biotech sector has recovered in the past month, with large drugmakers ...
On December 3, Guggenheim raised its price target on Eli Lilly and Company (NYSE:LLY) to $1,163 from $1,036 and kept a Buy ...
Eli Lilly stock (NYSE: LLY) is up 7% in a month, warranting investor attention following a key corporate development. Eli Lilly recently announced a significant partnership with Walmart to sell its ...
On November 18, JPMorgan analyst Chris Schott raised the firm’s price targ et on Eli Lilly and Company (NYSE:LLY) to $1,150 from $1,050 while maintaining an Overweig ht rating after meetings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback